Peregrine Asset Advisers’s AbbVie ABBV Stock Holding History

Peregrine Asset Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.51M	Sell	6,008 -113	-2%	-$24.3K	0.33%	73
2026 Q1	$1.33M	Buy	6,121 +1,684	+38%	+$374K	0.36%	68
2025 Q4	$1.01M	Hold	4,437	–	–	0.29%	76
2025 Q3	$1.03M	Hold	4,437	–	–	0.31%	76
2025 Q2	$824K	Sell	4,437 -100	-2%	-$18.6K	0.26%	81
2025 Q1	$951K	Sell	4,537 -125	-3%	-$24.3K	0.36%	71
2024 Q4	$828K	Sell	4,662 -836	-15%	-$154K	0.31%	78
2024 Q3	$1.09M	Buy	5,498 +173	+3%	+$32.3K	0.37%	75
2024 Q2	$913K	Hold	5,325	–	–	0.36%	69
2024 Q1	$970K	Buy	5,325 +100	+2%	+$17.2K	0.39%	65
2023 Q4	$810K	Hold	5,225	–	–	0.39%	69
2023 Q3	$779K	Buy	+5,225	New	+$767K	0.4%	63
2020 Q3	–	Sell	-18,589	Closed	-$1.82M	–	93
2020 Q2	$1.82M	Buy	+18,589	New	+$1.64M	1.04%	31
2015 Q3	–	Sell	-9,450	Closed	-$635K	–	86
2015 Q2	$635K	Sell	9,450 -275	-3%	-$18K	0.48%	39
2015 Q1	$569K	Sell	9,725 -275	-3%	-$16.6K	0.37%	63
2014 Q4	$654K	Hold	10,000	–	–	0.46%	56
2014 Q3	$578K	Hold	10,000	–	–	0.47%	54
2014 Q2	$564K	Sell	10,000 -32,625	-77%	-$1.71M	0.51%	53
2014 Q1	$2.19M	Sell	42,625 -450	-1%	-$22.7K	1.69%	19
2013 Q4	$2.27M	Buy	43,075 +37,725	+705%	+$1.85M	1.99%	15
2013 Q3	$239K	Buy	+5,350	New	+$237K	0.23%	111

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Peregrine Asset Advisers's ABBV Position: Q2 2026 in Review

Peregrine Asset Advisers reduced its AbbVie (ABBV) stake by 1.8% in Q2 2026, selling an estimated $24.3K and leaving 6,008 shares worth $1.51M. The position accounts for 0.33% of the portfolio, ranked #73.

Peregrine Asset Advisers first reported a position in ABBV in Q3 2013 and has held it in 21 quarters since. The position peaked at $2.27M in Q4 2013. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Peregrine Asset Advisers held 6,008 shares of AbbVie worth $1.51M as of Q2 2026.
Peregrine Asset Advisers sold 113 AbbVie shares in Q2 2026, an estimated $24.3K.
AbbVie made up 0.33% of Peregrine Asset Advisers's portfolio in Q2 2026, its #73 holding.
Peregrine Asset Advisers first reported a position in AbbVie in Q3 2013 and has held it in 21 quarters since.
Peregrine Asset Advisers's AbbVie position peaked at $2.27M in Q4 2013.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Peregrine Asset Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.